DIG-seq: a genome-wide CRISPR off-target profiling method using chromatin DNA.
Daesik KimJin-Soo KimPublished in: Genome research (2018)
To investigate whether and how CRISPR-Cas9 on-target and off-target activities are affected by chromatin in eukaryotic cells, we first identified a series of identical endogenous DNA sequences present in both open and closed chromatin regions and then measured mutation frequencies at these sites in human cells using Cas9 complexed with matched or mismatched sgRNAs. Unlike matched sgRNAs, mismatched sgRNAs were highly sensitive to chromatin states, suggesting that off-target but not on-target DNA cleavage is hindered by chromatin. We next performed Digenome-seq using cell-free chromatin DNA (now termed DIG-seq) and histone-free genomic DNA in parallel and found that only a subset of sites, cleaved in histone-free DNA, were cut in chromatin DNA, suggesting that chromatin can inhibit Cas9 off-target effects in favor of its genome-wide specificity in cells.
Keyphrases
- dna binding
- genome wide
- transcription factor
- cell free
- circulating tumor
- dna methylation
- crispr cas
- single molecule
- gene expression
- copy number
- dna damage
- genome editing
- induced apoptosis
- circulating tumor cells
- nucleic acid
- minimally invasive
- cell cycle arrest
- endoplasmic reticulum stress
- living cells
- mass spectrometry
- fluorescent probe